In the STEP 1 trial, participants receiving semaglutide 2.4 mg lost an average of 14.9% of their body weight over 68 weeks
The gap between trial and real-world tirzepatide vs semaglutide outcomes comes mostly from discontinuation and under-titration: only 25.9% of tirzepatide users reach 15 mg in practice, versus 83.5% of semaglutide users reaching 2.4 mg in the trial
Talk to your provider first about the benefits and risks of using Zepbound (tirzepatide) while breastfeeding
Ingredients Acetyl-L-carnitine hydrochloride, coating agent hydroxypropyl methylcellulose Important information: Dietary supplements must not be used as a substitute for a balanced, varied diet and a healthy lifestyle
For a time, pharmacies were able to make compounded versions of drugs that had semaglutide or tirzepatide as the active ingredient because of a shortage
A Team Member will reach out to you with a simple online medical form or simply click the link before or after your purchase, then call to schedule your evaluation